Resultados de la búsqueda 141-150 of 17429 for B cell lymphomas

  1. Hematología - Ensayos clínicos

    ... B-Cell Lymphoma (DLBCL). The Effects of Acute and Chronic Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...

  3. Linfoma difuso de células B grandes - Atención en Mayo Clinic

    Primary cutaneous marginal zone B-cell lymphoma (PCMZL). 30 Replies Tue, Feb 24, 2026. See more discussions. Relacionado. Procedimientos asociados. Biopsia de ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  7. Oncología (médica) - Ensayos clínicos

    Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study of JNJ‐68284528 Out‐of‐ ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...

  9. Oncología (médica) - Ensayos clínicos

    Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study of JNJ‐68284528 Out‐of‐ ...

  10. Hematología - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...